EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Bone marrow-derived CD133+ or nucleated cells for peripheral artery disease

The aim of this trial is to asses the safety and efficacy of intramuscular injection of either bone marrow-derived CD133+ cells or bone marrow-derived nucleated cells for the treatment of peripheral artery disease.
See additional Cell Therapies for: Endothelium
Bone marrow-derived CD133+ or nucleated cells for peripheral artery disease